News & Publications Press Releases Pulmovant presents positive proof-of-concept data from the Phase 1b ATMOS study of Mosliciguat in Pulmonary Hypertension at European Respiratory Society Congress Publications 2024 European Respiratory Society Congress ATMOS Poster
